Inhibitors of ribonucleic acid synthesis in Saccharomyces cerevisiae: decay rate of messenger ribonucleic acid.
Daunomycin and ethidium bromide, two deoxyribonucleic acid-intercalating drugs, inhibit ribonucleic acid (RNA) and protein synthesis in Saccharomyces cerevisiae. Both agents rapidly curtail uptake of radioactive adenine, whereas the kinetics of radioactive leucine uptake after drug addition are consistent with translation of a pool of exponentially decaying messenger RNA. Messenger RNA half-life determinations from these experiments gave identical results over a range of drug concentrations; this value is 21 +/- 4 min at 30 C. In a temperature-sensitive mutant in which RNA synthesis is curtailed at the nonpermissive temperature, a similar half-life for messenger RNA decay is found both in the absence and in the presence of either drug. This indicates that at the concentrations used in this study, neither daunomycin nor ethidium bromide has an appreciable direct effect on translation and do not increase the lability of messenger RNA.
D000225:Adenine / Q000378:metabolism; D002247:Carbon Isotopes; D003630:Daunorubicin / Q000494:pharmacology*; D004996:Ethidium / Q000494:pharmacology; D005656:Fungal Proteins / Q000096:biosynthesis; D007930:Leucine / Q000378:metabolism; D009154:Mutation; D010617:Phenanthridines / Q000494:pharmacology*; D014176:Protein Biosynthesis / Q000187:drug effects; D012313:RNA / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000378:metabolism*; D012441:Saccharomyces cerevisiae / Q000254:growth & development / Q000378:metabolism*; D013696:Temperature; D013997:Time Factors; D014158:Transcription, Genetic / Q000187:drug effects; D014316:Tritium
D002247:Carbon Isotopes; D005656:Fungal Proteins; D010617:Phenanthridines; D012333:RNA, Messenger; D014316:Tritium; D012313:RNA; D004996:Ethidium; D007930:Leucine; D000225:Adenine; D003630:Daunorubicin